“…In this complex scenario, it is acknowledged that many potential confounding factors, such as left-ventricle hypertrophy, diabetes mellitus, chronic kidney disease, microvascular disease or several drugs, may influence reperfusion injury and PC cardioprotective mechanisms, making a translation from bench to bedside even more difficult [11]. The protocol proposed by Koyama et al [10] addresses one issue, the better preservation of an acidic status in cardiomyocytes, but leaves many other important aspects of PC largely unaltered.…”